טוען...

Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab

BACKGROUND: There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G)...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS One
Main Authors: Hsiao, Chuan-Yu, Chiu, Hsien-Yi, Wang, Ting-Shun, Tsai, Tsen-Fang
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2017
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5590912/
https://ncbi.nlm.nih.gov/pubmed/28886099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184178
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!